Prospective Study Assessing Patient Satisfaction of Symptom Control With Proton Pump Inhibitor Dosing Regimen
| Status: | Recruiting |
|---|---|
| Conditions: | Gastroesophageal Reflux Disease |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2014 |
| Contact: | Abhijeet Waghray, MD |
| Email: | awaghray@metrohealth.org |
| Phone: | 216-778-3347 |
The overall aim of this study is to assess if patients with persistent GERD symptoms
receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when
prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking
omeprazole 30 minutes prior to the first meal of the day.
receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when
prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking
omeprazole 30 minutes prior to the first meal of the day.
Inclusion Criteria:
- ≥ 18 years old
- taking omeprazole 20 mg
- episodic heartburn at least 3 times per week
- provides consent and be willing to complete study questionnaires
- read, speak and write English
Exclusion Criteria:
- weight loss (alarm symptom)
- normal esophagogastroduodenoscopy (EGD) in last one year
- pregnant or women planning on becoming pregnant at any time during the study
- history of Barrett's esophagus
- prior esophageal strictures
- intolerance/allergy to study medications
- patients on plavix or a history of upper gastrointestinal surgery
- investigators or their immediate family (spouse, children, sibling)
We found this trial at
1
site
Click here to add this to my saved trials
